Part,  Chapter, Paragraph

 1   II,     5.  1.  1|          countries, cardiovascular complications and neoplasia represent
 2   II,     5.  1.  3|    condition and prevent avoidable complications, while maintaining or improving
 3   II,     5.  2.  3|             which represent common complications of AMI and require frequent
 4   II,     5.  4.  1|           and heart. Microvascular complications (diabetic retinopathy, nephropathy
 5   II,     5.  4.  1|            the occurrence of major complications is more difficult to avoid.
 6   II,     5.  4.  1|           a rise with the onset of complications. Indirect costs by diabetes
 7   II,     5.  4.  1|   representation.~Severe long term complications are observed in both forms
 8   II,     5.  4.  1|           in the increased risk of complications, affecting both small blood
 9   II,     5.  4.  1|            vessels (macro-vascular complications including vision loss, nerve
10   II,     5.  4.  1|            vessels (macro-vascular complications such as myocardial infarction
11   II,     5.  4.  1|         prevent and/or reduce such complications.~Main complications of diabetes
12   II,     5.  4.  1|           such complications.~Main complications of diabetes are as follows:~
13   II,     5.  4.  1|         stillbirth.~Cardiovascular complications: Long lasting hyperglycaemia
14   II,     5.  4.  2|       targets for the reduction of complications and the development of an
15   II,     5.  4.  2|      paramount to prevent diabetes complications, but it is not an easy matter
16   II,     5.  4.  2|      diabetes and particularly its complications - blindness, renal failure,
17   II,     5.  4.  2|        linked to the occurrence of complications, is increasingly considered
18   II,     5.  4.  2|       define estimates of rates of complications that are frequently recorded
19   II,     5.  4.  2|         system on diabetes and its complications of this nature across Europe.
20   II,     5.  4.  2|      Registries~IV Epidemiology of complications~ ~ ~Annual incidence of
21   II,     5.  4.  2|    patients die from macrovascular complications, which lead to record diabetes
22   II,     5.  4.  2|        only~2~III Risk factors for complications~ ~Percent of diabetic subjects
23   II,     5.  4.  2|         bands~2~IV Epidemiology of complications~ ~Percent of diabetic subjects
24   II,     5.  4.  2|            that can lead to severe complications. It is defined as the percentage
25   II,     5.  4.  2|        existence of ophthalmologic complications. The process indicator is
26   II,     5.  4.  3|         burden of diabetes and its complications, remain scarce both in the
27   II,     5.  4.  6|       tools and policies~Long term complications, observed in both forms
28   II,     5.  4.  6|   considerably to the reduction of complications, something even more important
29   II,     5.  4.  6|   non-diagnosed patients (prior to complications), which translates into
30   II,     5.  4.  6|      diagnosis made when the first complications are already present.~According
31   II,     5.  4.  6|            of this disease and its complications, as well as the possible
32   II,     5.  4.  6|          diabetes mellitus and its complications in the EU requires carefully
33   II,     5.  4.  6|          the reduction of diabetes complications. A fundamental guideline
34   II,     5.  4.  6|            development of diabetes complications;~· Adoption of a holistic,
35   II,     5.  4.  7|    clinical measurements, diabetes complications);~· health system (structures,
36   II,     5.  5.  3|      sexual dysfunction, obstetric complications, cardiovascular diseases,
37   II,     5.  5.  3|           types, circumstances and complications: a European cohort study.
38   II,     5.  7.  1|            risk for cardiovascular complications. Independent from other
39   II,     5.  7.  1|            risk for cardiovascular complications which is 2-4 times higher
40   II,     5.  7.  1|           resulting cardiovascular complications (Chobanian et al, 2003;
41   II,     5.  7.  1|           death and other clinical complications in other chronic diseases
42   II,     5.  7.  3|       showing a higher risk for CV complications and for evolution to ESRD (
43   II,     5.  7.  5|          for CKD. When the risk of complications due to modifiable factors
44   II,     5.  8.  1| co-morbidities and severe systemic complications.~ ~Major efforts in the
45   II,     5.  8.  3|        COPD follow-up, 25% to COPD complications and exacerbations, and 34%
46   II,     5. 12.  5|           it is possible to reduce complications and related mortality through
47   II,     6.  3.  3|           lead to severe long-term complications such as ectopic (outside
48   II,     6.  3.  5|            may suffer from serious complications, including deafness, neurological
49   II,     9        |           intrapartum and neonatal complications including pregnancy induced
50   II,     9.  1    |         status are associated with complications of the perinatal period,
51   II,     9.  1.  1|        Elevated risks of pregnancy complications and adverse outcomes with
52   II,     9.  1.  2|           intrapartum and neonatal complications including pregnancy induced
53   II,     9.  3.  2|            more frequent obstetric complications and diseases. Maternal morbidity
54   II,     9.  3.  2|     infections/sepsis, obstetrical complications, and ‘indirectcauses,
55   II,     9.  3.  2|        Elevated risks of pregnancy complications and adverse outcomes with
56   II,     9.  4.  3|       Federation, 2003). Long-term complications affect older people making
57  III,    10.  2.  1|           in pregnancy~- Pregnancy complications~- Preterm delivery~- Foetal
58  III,    10.  2.  1|      pregnancy and early childhood complications. The association with the
59  III,    10.  2.  1|           and can lead to surgical complications and a greater likelihood
60  III,    10.  2.  1|       consumption patterns and the complications caused by the combined use
61  III,    10.  4.  2|           included with associated complications regarding the tasks EFSA
62   IV,    11.  1.  5|        delivery, miscommunication, complications in payment systems, etc. (
63   IV,    11.  1.  5|            lead to greater medical complications or even deaths. In addition,
64   IV,    12.  2    |               Diabetes~ ~Long term complications, observed in both forms
65   IV,    12.  2    |   non-diagnosed patients (prior to complications) with the diagnosis made
66   IV,    12.  2    |      diagnosis made when the first complications are already present.~ ~The